Paul T. Spellman

Paul T. Spellman is a Professor in the Department of Molecular and Medical Genetics at Oregon Health & Science University (OHSU) School of Medicine. He also serves as co-leader of the Quantitative Oncology Program at the OHSU Knight Cancer Institute. His research focuses on leveraging genetic and genomic approaches to understand cancer development, monitor disease progression, and identify therapeutic strategies. Specific interests include population genetics for cancer risk assessment, computational analysis of genomic data to detect early cancer changes, and public education on genetics-related cancer risks.

• Education: Ph.D. in Genetics from Stanford University.

Dr. Spellman's research integrates computational methods with biomedical applications, emphasizing translational oncology. His work spans risk stratification, early detection, and precision medicine. He actively contributes to interdisciplinary initiatives through affiliations like the OHSU Center for Spatial Systems Biomedicine.

• Awards: Penny and Phil Knight Professorship in Cancer Research Innovation.

His contributions include advancing genomic data analysis frameworks and fostering collaborations to translate research into clinical practice. He remains committed to bridging gaps between genetic science and public health education.